Abbott Laboratories Raises 2026 Profit Forecast

Abbott Laboratories revised its 2026 profit forecast upward following its second-quarter financial results. The company reported stronger-than-expected performance across most of its business units. Robust sales growth in the second quarter positively impacted Abbott's profit margins. Anticipating continued positive momentum, the company set a higher profit target for 2026. Increased sales across Abbott's diverse segments, including medical devices, diagnostic products, and nutrition, contributed to overall growth. The company remains confident that this trend will continue. This is not an investment recommendation.